drugset

drugset / Trial / NCT05218759

Exosomes Detection for the Prediction of the Efficacy and Adverse Reactions of Anlotinib in Patients With Advanced NSCLC

NCT05218759 ↗

Unknown 30 enrolled Shanghai Chest Hospital 3D Medicines · collab

RandomizedParallel-groupOpen-labelDiagnostic

Summary

Exosomes detection for the prediction of the efficacy and adverse reactions of Anlotinib in patients with advanced NSCLC

Timeline

Start: 2022-02-21
Primary completion: 2025-05-31
Completion: 2025-10-31

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Catequentinib	Small molecule	10 mg	—

Indications